Latest News from Pro PG

Sourcing a medicine is only the first step in Australian market access. See how ProPG supports pharmaceutical companies across access pathways, import coordination, cold-chain storage and hospital distribution.

When a medicine becomes unavailable in Australia, several access pathways may be relevant. This guide explains Section 19A, SAS Categories A, B and C, Authorised Prescriber and the practical realities of sourcing overseas medicines.

Section 19A and the Special Access Scheme are both routes to medicines that aren't on the ARTG — but they exist for different reasons and are triggered by different people. Here's how hospital pharmacists, procurement teams and pharmaceutical companies can tell which pathway applies, and why the distinction matters for supply planning.

Fludarabine Phosphate Injection, USP 50mg/2mL (25mg/mL) Single-Dose Vial (Fresenius Kabi, USA)

Dear Healthcare Professional, Shortage of FLUDARABINE JUNO fludarabine phosphate 50 mg powder for injection vial (AUST R: 147831) Pro Pharmaceuticals Group recognises the importance of maintaining access to essential medicines in Australia and would like to provide an update regarding the supply of fludarabine phosphate injection. The Australian-registered medicine, FLUDARABINE JUNO fludarabine phosphate 50 mg powder for injection vial (AUST R: 147831), sponsored by Juno Pha

Shortage of BICILLIN L-A benzathine benzylpenicillin

Dear Healthcare Professional, Shortage of DEPTRAN 10 doxepin 10mg (as hydrochloride) capsule blister pack (AUST R: 308999) Pro Pharmaceuticals Group recognises the importance of supplying essential medicines in Australia and would like to advise you the change in supply status of DEPTRAN 10 doxepin 10mg (as hydrochloride) capsule blister pack (AUST R: 308999) in Australia. The Australian registered medicine, DEPTRAN 10 doxepin 10mg (as hydrochloride) capsule blister pac

Australian registered LARIAM® mefloquine 250 mg tablets are currently in limited availability. The TGA has granted Section 19A approval for temporary supply of Mefloquine Hydrochloride 250 mg tablets from Canada to ensure continuity of malaria treatment and prophylaxis. Pro Pharmaceuticals Group now supports supply to Australian healthcare institutions.

Historical supply notice: This article relates to a previous medicine shortage or regulatory approval. Availability and regulatory status may have changed. Healthcare professionals should contact Pro Pharmaceuticals Group to confirm the current supply position. For current Australian shortage and supply information, see medicine shortages in Australia. Dear Healthcare Professional, Shortage of RESPRIM FORTE trimethoprim/sulfamethoxazole 160 mg/800 mg tablet blister pack Pro P

Drug Shortage: 0.9% Sodium Chloride Injection Bags 1000ml